HomeERIS • NSE
add
Eris Lifesciences Ltd
Previous close
â‚ą871.20
Day range
â‚ą852.40 - â‚ą884.95
Year range
â‚ą605.00 - â‚ą971.90
Market cap
119.03B INR
Avg Volume
104.96K
P/E ratio
30.85
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 4.83B | 15.71% |
Operating expense | 2.65B | 19.42% |
Net income | 1.03B | 0.86% |
Net profit margin | 21.25 | -12.84% |
Earnings per share | 7.54 | — |
EBITDA | 1.56B | 27.90% |
Effective tax rate | 12.44% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.91B | 168.64% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 24.28B | — |
Shares outstanding | 136.07M | — |
Price to book | 4.91 | — |
Return on assets | — | — |
Return on capital | 9.96% | — |
Cash Flow
Net change in cash
(INR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 1.03B | 0.86% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2007
Website
Employees
3,548